## ALL: Allstate Corporation (The) - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.19 indicates fundamental undervaluation. Quality metrics strong (ROE 34%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-5.8% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($201.95)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Allstate (ALL) president exercises $62.32 options, sells stock at ~$215 in 10b5-1 trades**
- Source: Stock Titan | 20251202T040907 | Neutral | Relevance: 97%
-  Suren Gupta, President of Enterprise Solutions at The Allstate Corporation, exercised employee stock options to purchase 4,536 shares of Allstate common stock at $62.32 per share across two dates in late November 2025. Concurrently, he sold the same number of shares on the open market at weighted average prices of approximately $215, all in accordance with a Rule 10b5-1(c) trading plan established on June 9, 2025. After these transactions, Gupta directly beneficially owns 100,646 Allstate shares and retains 19,593 employee stock options.

**2. 10 Largest Auto Insurance Companies (December 2025)**
- Source: ValuePenguin | 20251202T120842 | Neutral | Relevance: 73%
-  This article identifies the 10 largest auto insurance companies in the U.S. for December 2025, with State Farm leading the market share. It provides detailed profiles of each company, including their market share, premiums, customer satisfaction ratings, and key features. The article also offers a comparison between large and small insurance companies and expert insights on market perception, customer satisfaction, and the role of localized agents in the digital age.

**3. American Century Companies Inc. Purchases 99,126 Shares of Aptiv PLC $APTV**
- Source: MarketBeat | 20251130T081343 | Somewhat-Bullish | Relevance: 65%
- American Century Companies Inc. increased its stake in Aptiv PLC (NYSE:APTV) by 24.0% during the second quarter, acquiring an additional 99,126 shares and bringing its total holdings to 512,467 shares worth approximately $34.96 million. Other institutional investors also adjusted their positions in Aptiv, while insider trading saw CAO Allan J. Brazier sell 1,000 shares. Analyst ratings for Aptiv range from "Strong Buy" to "Sell," with a consensus "Moderate Buy" rating and an average target price of $95.42.

**4. Inceptionr LLC Trims Stock Holdings in Aptiv PLC $APTV**
- Source: MarketBeat | 20251130T111033 | Neutral | Relevance: 60%
- Inceptionr LLC significantly reduced its stake in Aptiv PLC by 46% during Q2 2025, selling 4,284 shares and ending the quarter with 5,022 shares valued at approximately $343,000. Meanwhile, Aptiv exceeded quarterly expectations with strong EPS and revenue results, setting optimistic FY2025 guidance. Corporate insiders also engaged in stock sales, with CAO Allan J. Brazier selling 1,000 shares.

**5. Prudential Financial Inc. Grows Holdings in Aptiv PLC $APTV**
- Source: MarketBeat | 20251130T104947 | Neutral | Relevance: 60%
- Prudential Financial Inc. significantly increased its stake in Aptiv PLC by 335.4% in Q2, now owning 143,053 shares valued at $9.76 million. Other major institutional investors, including Goldman Sachs, also boosted their holdings, resulting in institutional investors owning 94.21% of Aptiv's stock. Aptiv exceeded Q3 estimates and analysts maintain a "Moderate Buy" rating with an average target price of $95.42.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-26 | Roth Capital | $240 | $230 | +4% |
| 2025-11-11 | Keefe, Bruyette | $250 | $246 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-26 | Roth Capital | main | Buy |
| 2025-11-11 | Keefe, Bruyette | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.12M) |
| Sells | 12 ($11.17M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (-0.3%)
- Blackrock Inc.: 8.5% (-1.0%)
- Price (T.Rowe) Assoc: 4.9% (-17.0%)
- State Street Corpora: 4.5% (+0.7%)
- Geode Capital Manage: 2.7% (+3.3%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-5.8% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $11M sold (12 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.19 suggests fair value with growth premium. Quality metrics strong (ROE 34%). Balance sheet: strong liquidity (30938000000.0x), $3.2B free cash flow. Insider selling cluster ($11.2M in 90 days), potential headwind. Institutional flow bearish (8 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $53.0B |
| Beta | 0.25 |
| 52W Range | $176.00 - $215.89 |
| Short Interest | 1.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.19 |
| Forward P/E | 8.7 |
| Current P/E | 7.3 |
| YoY Growth | -15.5% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 4.5% to -1.3% (-5.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.3pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 54.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.33% (CS: 43) | Neutral |
| RSI_14 | 53.7 | Neutral |
| MACD Histogram | -0.05 | Bearish |
| vs SMA20 | 1.004x | Above |
| vs SMA50 | 1.021x | Above |
| vs SMA200 | 1.038x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $208.91
- **Stop Loss:** $201.95 (3.3% risk)
- **Target:** $222.83 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 71
- **Position Value:** $14,832.61
- **Portfolio %:** 14.83%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-04 (Est: $8.25)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $7.54 | $11.17 | +48.1% |
| 2025Q2 | $3.26 | $5.94 | +82.4% |
| 2025Q1 | $2.53 | $3.53 | +39.3% |
| 2024Q4 | $6.28 | $7.67 | +22.1% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*